---
title: "GERTZ BARRY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/990a216f-dcbf-5924-9b9d-e81082ee5aa6
json: https://whiteintel.dev/api/public/dossier/990a216f-dcbf-5924-9b9d-e81082ee5aa6
identifier: sec:0001631100
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GERTZ BARRY

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001631100`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/990a216f-dcbf-5924-9b9d-e81082ee5aa6  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/990a216f-dcbf-5924-9b9d-e81082ee5aa6  

## Ownership & control

### Holdings / subsidiaries

- **Carisma Therapeutics Inc.** (director) — https://whiteintel.dev/entity/a9fad273-9024-53b6-8c78-027b6762d4e2

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GERTZ BARRY**. Human view: https://whiteintel.dev/entity/990a216f-dcbf-5924-9b9d-e81082ee5aa6 · Structured JSON: https://whiteintel.dev/api/public/dossier/990a216f-dcbf-5924-9b9d-e81082ee5aa6._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._